A multicenter, open-label, randomized, two-treatment, two- sequence, two-period, cross-over, steady-state clinical Bio-equivalence study of Clozapine 100 mg tablet of Aurobindo (test) with Clozaril (Clozapine) 100 mg tablet of Novartis (reference) in schizophrenic patients already receiving/ stabilized with Clozapine under fasting conditions.
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Clozapine (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Aurobindo Pharma
- 27 Nov 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India record.
- 05 Jul 2013 New trial record
- 20 Jun 2013 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India record.